Intuitive Surgical (ISRG)
Market Price (9/12/2025): $454.0 | Market Cap: $162.8 BilSector: Health Care | Industry: Health Care Equipment
Intuitive Surgical (ISRG)
Market Price (9/12/2025): $454.0Market Cap: $162.8 BilSector: Health CareIndustry: Health Care Equipment
Investment Highlights
Attractive operating marginsOp Mgn LTMOperating Margin = Operating Income / Revenue Reflects profitability before taxes and before impact of capital structure (interest payments). is 29% | Expensive valuation multiplesP/EBITPrice/EBIT or Price/(Operating Income) ratio is 62x, P/CFOPrice/(Cash Flow from Operations). CFO is cash before capital expenditures. is 58x, P/EPrice/Earnings or Price/(Net Income) is 63x | |
Attractive cash flow generationCFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is 31%, FCF/Rev LTMFree Cash Flow / Revenue (Sales), Last Twelve Months (LTM) is 22%, CFO LTM is 2.8 Bil | Yield minus risk free rate is negativeERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is -2.9% | |
Low stock price volatilityVol 12M is 33% |
Attractive operating marginsOp Mgn LTMOperating Margin = Operating Income / Revenue Reflects profitability before taxes and before impact of capital structure (interest payments). is 29% |
Attractive cash flow generationCFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is 31%, FCF/Rev LTMFree Cash Flow / Revenue (Sales), Last Twelve Months (LTM) is 22%, CFO LTM is 2.8 Bil |
Low stock price volatilityVol 12M is 33% |
Expensive valuation multiplesP/EBITPrice/EBIT or Price/(Operating Income) ratio is 62x, P/CFOPrice/(Cash Flow from Operations). CFO is cash before capital expenditures. is 58x, P/EPrice/Earnings or Price/(Net Income) is 63x |
Yield minus risk free rate is negativeERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is -2.9% |
Market Valuation
9/12/25 | 2024 | 2023 | 2022 | 2021 | |
---|---|---|---|---|---|
Share Price CYE | $454.00 | $521.96 | $337.36 | $265.35 | $359.30 |
Market Cap CYE ($ Bil) | 162.8 | 186.0 | 118.7 | 93.2 | 128.5 |
Total Debt ($ Bil) | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 |
Total Cash ($ Bil) | 5.3 | 4.0 | 5.2 | 4.1 | 4.2 |
Enterprise Value ($ Bil) | 157.4 | 186.0 | 118.7 | 93.2 | 128.6 |
Valuation Ratios | |||||
P/S TTM | 17.8 | 22.2 | 16.6 | 15.2 | 22.4 |
P/EBIT TTM | 61.8 | 78.9 | 67.1 | 59.9 | 70.3 |
P/E TTM | 62.4 | 79.8 | 65.9 | 71.4 | 75.1 |
Sector Ratios | |||||
P/S TTM (Sector) | 3.8 | 3.6 | 4.1 | 4.5 | 7.3 |
P/EBIT TTM (Sector) | -1.6 | -1.3 | -1.4 | -1.3 | -2.9 |
P/E TTM (Sector) | -1.8 | -1.6 | -1.5 | -1.4 | -2.9 |
9/12/25 | 2024 | 2023 | |
---|---|---|---|
Share Price CYE | $454.00 | $521.96 | $337.36 |
Market Cap CYE ($ Bil) | 162.8 | 186.0 | 118.7 |
Total Debt ($ Bil) | 0.0 | 0.0 | 0.0 |
Total Cash ($ Bil) | 5.3 | 4.0 | 5.2 |
Enterprise Value ($ Bil) | 157.4 | 186.0 | 118.7 |
Valuation Ratios | |||
P/S TTM | 17.8 | 22.2 | 16.6 |
P/EBIT TTM | 61.8 | 78.9 | 67.1 |
P/E TTM | 62.4 | 79.8 | 65.9 |
Sector Ratios | |||
P/S TTM (Sector) | 3.8 | 3.6 | 4.1 |
P/EBIT TTM (Sector) | -1.6 | -1.3 | -1.4 |
P/E TTM (Sector) | -1.8 | -1.6 | -1.5 |
Business Description
Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System to enable complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.
Show more
Price Returns Compared
Expand for Detailed View2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Total [1] | |
---|---|---|---|---|---|---|---|
Returns | |||||||
ISRG Return | 38% | 32% | -26% | 27% | 55% | -13% | 140% |
Peers Return | 3% | 12% | -12% | 12% | 14% | 7% | 39% |
S&P 500 Return | 16% | 27% | -19% | 24% | 23% | 12% | 101% |
[1] Cumulative total returns since the beginning of 2020
[2] Peers: BSX, SYK, MDT, BDX, EW. See ISRG Returns vs. Peers.
[3] 2025 data is for the year up to 9/11/2025 (YTD)
Latest Trefis Analyses
Research & Analysis
Invest in Strategies
Wealth Management
Peer Comparisons for Intuitive Surgical
Financials
Median | |
---|---|
Name | |
Mkt Price | 147.45 |
Mkt Cap | 134.7 |
Rev LTM | 19,940 |
Op Inc LTM | 3,172 |
FCF LTM | 2,892 |
FCF 3Y Avg | 2,309 |
CFO LTM | 3,770 |
CFO 3Y Avg | 3,146 |
Growth & Margins
Median | |
---|---|
Name | |
Rev Chg LTM | 10.2% |
Rev Chg 3Y Avg | 7.3% |
Rev Chg Q | 11.5% |
QoQ Delta Rev Chg LTM | 2.8% |
Op Mgn LTM | 19.5% |
Op Mgn 3Y Avg | 18.9% |
QoQ Delta Op Mgn LTM | 0.1% |
CFO/Rev LTM | 20.5% |
CFO/Rev 3Y Avg | 18.0% |
FCF/Rev LTM | 16.2% |
FCF/Rev 3Y Avg | 13.6% |
Valuation
Median | |
---|---|
Name | |
Mkt Cap | 134.7 |
P/S | 7.1 |
P/EBIT | 29.5 |
P/E | 42.7 |
P/CFO | 33.6 |
Total Yield | 3.9% |
Dividend Yield | 0.4% |
FCF Yield 3Y Avg | 2.0% |
D/E | 0.1 |
Net D/E | 0.1 |
Returns
Median | |
---|---|
Name | |
1M Rtn | 1.5% |
3M Rtn | 4.3% |
6M Rtn | 5.6% |
12M Rtn | 7.4% |
3Y Rtn | 43.0% |
1M Excs Rtn | -0.7% |
3M Excs Rtn | -5.2% |
6M Excs Rtn | -11.6% |
12M Excs Rtn | -12.6% |
3Y Excs Rtn | -9.3% |
Comparison Analyses
Returns Analyses
Earnings Returns History
Expand for MoreForward Returns | |||
---|---|---|---|
Earnings Date | 1D Returns | 5D Returns | 21D Returns |
7/22/2025 | -1.8% | -2.8% | -6.0% |
4/22/2025 | 1.9% | 7.6% | 14.3% |
1/15/2025 | 7.7% | 13.3% | 9.7% |
10/17/2024 | 10.0% | 8.0% | 11.4% |
7/18/2024 | 9.3% | 5.0% | 15.1% |
4/18/2024 | -1.7% | 0.1% | 7.0% |
1/9/2024 | 10.3% | 8.6% | 17.1% |
10/19/2023 | -2.4% | -5.1% | 11.6% |
... | |||
SUMMARY STATS | |||
# Positive | 15 | 17 | 18 |
# Negative | 9 | 7 | 6 |
Median Positive | 7.0% | 4.3% | 9.1% |
Median Negative | -2.4% | -5.5% | -10.4% |
Max Positive | 10.9% | 22.8% | 35.8% |
Max Negative | -14.3% | -17.4% | -25.6% |
SEC Filings
Expand for MoreReport Date | Filing |
---|---|
6302025 | 10-Q 6/30/2025 |
3312025 | 10-Q 3/31/2025 |
12312024 | 10-K 12/31/2024 |
9302024 | 10-Q 9/30/2024 |
6302024 | 10-Q 6/30/2024 |
3312024 | 10-Q 3/31/2024 |
12312023 | 10-K 12/31/2023 |
9302023 | 10-Q 9/30/2023 |
6302023 | 10-Q 6/30/2023 |
3312023 | 10-Q 3/31/2023 |
12312022 | 10-K 12/31/2022 |
9302022 | 10-Q 9/30/2022 |
6302022 | 10-Q 6/30/2022 |
3312022 | 10-Q 3/31/2022 |
12312021 | 10-K 12/31/2021 |
9302021 | 10-Q 9/30/2021 |
Insider Activity
Expand for MoreOwner | Title | Filing Date | Action | Price | Shares | TransactedValue | Value ofHeld Shares | Form | |
---|---|---|---|---|---|---|---|---|---|
0 | Brosius Mark | SVP & Chief Mfg and Supply Cha | 6062025 | Sell | 560.70 | 215 | 120,551 | 629,666 | Form |
1 | Brosius Mark | SVP & Chief Mfg and Supply Cha | 6042025 | Sell | 549.06 | 215 | 118,048 | 970,738 | Form |
2 | Brosius Mark | SVP & Chief Mfg and Supply Cha | 5162025 | Sell | 560.00 | 22 | 12,320 | 1,121,680 | Form |
3 | Brosius Mark | SVP & Chief Mfg and Supply Cha | 5142025 | Sell | 551.97 | 22 | 12,143 | 1,142,026 | Form |
4 | LOEB GARY | EVP & Chief Legal and Complian | 4252025 | Sell | 513.18 | 1,700 | 872,406 | 1,152,089 | Form |
External Quote Links
Y Finance | Barrons |
TradingView | Morningstar |
SeekingAlpha | ValueLine |
Motley Fool | Robinhood |
CNBC | Etrade |
MarketWatch | Unusual Whales |
YCharts | Perplexity Finance |
FinViz |